September 21, 2022 07:14 AM EDT
Pharma
FDA+

Two CRLs lat­er, FDA en­dors­es drug to pre­vent hear­ing loss as­so­ci­at­ed with chemo

Amber Tong

Af­ter re­ject­ing it twice, the FDA has fi­nal­ly ap­proved a new drug for low­er­ing the risk of hear­ing loss among chil­dren be­ing treat­ed for can­cer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Food al­ler­gy biotech Al­ladapt clos­es af­ter Phase 3 talks with FDA

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Soleno’s rare pe­di­atric dis­ease drug faces PDU­FA de­lay by three months

A service from the Financial Times